Chronic kidney disease and venous thromboembolism: Epidemiology and mechanisms

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 5, 2009, Pages 408-412

  Wattanakit, Keattiyoat ^a   Cushman, Mary ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Blood coagulation; Kidney disease; Risk factor; Venous thromboembolism

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR; CREATININE; CYSTATIN C; PADGEM PROTEIN; PROCOAGULANT; PROTEIN C; PROTEIN S;

BLOOD CLOTTING DISORDER; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FIBRINOLYSIS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOSTASIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LUNG EMBOLISM; MICROALBUMINURIA; NEPHROTIC SYNDROME; PREVALENCE; RECURRENT DISEASE; REVIEW; RISK FACTOR; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VENOUS THROMBOEMBOLISM;

HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; RISK FACTORS; UNITED STATES; VENOUS THROMBOEMBOLISM; WORLD HEALTH;

EID: 68949190810     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832ee371     Document Type: Review

References (44)

1. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44:62-69.
2. Silverstein RL, Bauer KA, Cushman M, et al. Venous thrombosis in the elderly: more questions than answers. Blood 2007; 110:3097-3101.
3. Virchow R. Phlogose und Thrombose im Gefä ßsystem; Gesammelte Abhandlungen zur Wissenschaftlichen Medizin Frankfurt, Germany; 1856.
4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc 2007; 298:2038-2047. (Pubitemid 350074801)
5. US Renal Data Systems. USRDS 2006 Annual Data Report: Atlas of end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
6. Kottgen A, Selvin E, Stevens LA, et al. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2008; 51:385-394.
7. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
8. Guntupalli K, Soffer O, Baciewicz P. Pulmonary embolism in end stage renal disease. Intensive Care Med 1990; 16:405-407.
9. Mossey RT, Kasabian AA, Wilkes BM, et al. Pulmonary embolism: low incidence in chronic renal failure. Arch Intern Med 1982; 142:1646-1648.
10. Rotter W, Roettger P. Comparative pathologic-anatomic study of cases of chronic global renal insufficiency with and without preceding hemodialysis. Clin Nephrol 1973; 1:257-265.
11. Wiesholzer M, Kitzwogerer M, Harm F, et al. Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. Am J Kidney Dis 1999; 33:702-708.
12. Tveit DP, Hypolite IO, Hshieh P, et al. Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 2002; 39:1011 -101 7. (Pubitemid 34454219)
13. Wattanakit K, Cushman M, Stehman-Breen C, et al. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 2008;19:135-140.
14. Mahmoodi BK, Gansevoort RT, Veeger NJ, et al. Microalbuminuria and risk of venous thromboembolism. J Am Med Assoc 2009; 301:1790-1797.
15. Llach F, PapperS, MassrySG. The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med 1980; 69:819-827.
16. Lilova MI, Velkovski IG, Topalov IB. Thromboembolic complications in children with nephrotic syndrome in Bulgaria (1974-1996). Pediatr Nephrol 2000; 15:74-78.
17. Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008; 117:224-230.
18. Velasquez Forero F, Garcia Prugue N, Ruiz Morales N. Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol 1988; 8:457-462.
19. Kayali F, Najjar R, Aswad F, et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med 2008; 121:226-230.
20. Abbott KC, Cruess DF, Agodoa LY, et al. Early renal insufficiency and late venous thromboembolism after renal transplantation in the United States. Am J Kidney Dis 2004; 43:120-130.
21. Poli D,ZanazziM,Antonucci E, etal. High rate of recurrence in renal transplant recipients after a first episode of venous thromboembolism. Transplantation 2005; 80:789-793. (Pubitemid 41443761)
22. Keller C, Katz R, Cushman M, et al. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol 2008; 9:9.
23. Vaziri ND, Branson HE, Ness R. Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome. Am J Med Sci 1980; 280:167-171.
24. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107:87-92.
25. Kraaijenhagen RA, in't Anker PS, Koopman MM, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83:5-9.
26. Koster T, Blann AD, Briet E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345:152-155.
27. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95:3678-3682.
28. Meijers JC, Tekelenburg WL, Bouma BN, et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 2000; 342:696-701.
29. van Hylckama Vlieg A, Rosendaal FR. High levels of fibrinogen are associated with the risk of deep venous thrombosis mainly in the elderly. J Thromb Haemost 2003; 1:2677-2678.
30. Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 2003; 101:1243-1248.
31. Vaziri ND, Paule P, Toohey J, etal. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 1984; 144:1802-1803. (Pubitemid 14070038)
32. Marciniak E, Farley CH, DeSimone PA. Familial thrombosis due to antithrombin 3 deficiency. Blood 1974; 43:219-231.
33. Robert A, Olmer M, Sampol J, et al. Clinical correlation between hypercoagul-ability and thrombo-embolic phenomena. Kidney Int 1987; 31:830-835.
34. Cosio FG, Batard MA, Brandt JT, Griffin JH. Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria. J Lab Clin Med 1985; 106:218-222.
35. Allon M, Soffer O, Evatt BL, et al. C antigen levels in proteinuric patients: dependence on type of glomerular pathology. Am J Hematol 1989; 31:96-101.
36. Sirolli V, Ballone E, Garofalo D, et al. Platelet activation markers in patients with nephrotic syndrome. A comparative study of different platelet function tests. Nephron 2002; 91:424-430.
37. Tkaczyk M, Baj Z. Surface markers of platelet function in idiopathic nephrotic syndrome in children. Pediatr Nephrol 2002; 17:673-677.
38. Jackson CA, Greaves M, Patterson AD, et al. Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 1982; 52:69-77.
39. Schieppati A, Dodesini P, Benigni A, et al. The metabolism of arachidonic acid by platelets in nephrotic syndrome. Kidney Int 1984; 25:671-676.
40. Ay C, Simanek R, Vormittag R, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS). Blood 2008; 112:2703-2708.
41. Kyrle PA, Hron G, Eichinger S, Wagner O. Circulating P-selectin and the risk of recurrent venous thromboembolism. Thromb Haemost 2007; 97:880-883. (Pubitemid 46939199)
42. Folsom AR, Cushman M, Heckbert SR, et al. Prospective study of fibrinolytic markers and venous thromboembolism. J Clin Epidemiol 2003; 56:598-603.
43. Lisman T, de Groot PG, Meijers JC, Rosendaal FR. Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood 2005; 105:1102-1105.
44. Lau SO, Tkachuck JY, Hasegawa DK, Edson JR. Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminogenuria and antithrombinuria. J Pediatr 1980; 96:390-392.